Kiss I - Search Results

1

Changes in expression of oncogenes and TP53 tumour suppressor gene as biomarkers in head and neck cancers.

Szanyi I, Bauer M, Gerlinger I, Járai T, Gobel G, Lujber L, Szabadi E, Fehér K, Émber A, Ember I, Kiss I. Szanyi I, et al. Among authors: kiss i. Eur Arch Otorhinolaryngol. 2011 Jul;268(7):1041-6. doi: 10.1007/s00405-010-1425-6. Epub 2010 Dec 1. Eur Arch Otorhinolaryngol. 2011. PMID: 21120662

2

Effects of cytochrome P450 1A1 and uridine-diphosphate-glucuronosyltransferase 1A1 allelic polymorphisms on the risk of development and the prognosis of head and neck cancers.

Szanyi I, Ráth G, Móricz P, Somogyvári K, Révész P, Gerlinger I, Orsós Z, Ember I, Kiss I. Szanyi I, et al. Among authors: kiss i. Eur J Cancer Prev. 2012 Nov;21(6):560-8. doi: 10.1097/CEJ.0b013e328350b04c. Eur J Cancer Prev. 2012. PMID: 22273851

3

In vivo effects of cyclophosphamide on oncogene and suppressor gene expression in a "follow up" study.

Ember I, Kiss I. Ember I, et al. Among authors: kiss i. Anticancer Res. 1997 Sep-Oct;17(5A):3593-7. Anticancer Res. 1997. PMID: 9413208

4

In vivo effects of afobazole (2-mercaptobenzimidazole derivative) on the 7,12-dimethylbenz [alpha]anthracene-induced oncogene and suppressor gene expression.

Szanyi I, Lujber L, Gerlinger I, Pytel J, Bauer M, Csejtey A, Szele E, Gombos K, Kiss I, Seredenin S, Yarkova M, Ember I. Szanyi I, et al. Among authors: kiss i. In Vivo. 2007 Nov-Dec;21(6):1059-63. In Vivo. 2007. PMID: 18210756 Free article.

5

Early modification of c-myc, Ha-ras and p53 expressions by chemical carcinogens (DMBA, MNU).

Budán F, Varjas T, Nowrasteh G, Prantner I, Varga Z, Ember A, Cseh J, Gombos K, Pázsit E, Gobel G, Bauer M, Gracza T, Arany I, Perjési P, Ember I, Kiss I. Budán F, et al. Among authors: kiss i. In Vivo. 2009 Jul-Aug;23(4):591-8. In Vivo. 2009. PMID: 19567395 Free article.

6

Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population.

Csejtei A, Tibold A, Koltai K, Varga Z, Szanyi I, Gobel G, Prantner I, Steffler D, Feher G, De Blasio A, Ember I, Kiss I. Csejtei A, et al. Among authors: kiss i. Anticancer Res. 2009 Oct;29(10):4169-73. Anticancer Res. 2009. PMID: 19846968 Free article.

7

Long-term effects of 1-nitropyrene on oncogene and tumor suppressor gene expression.

Gyöngyi Z, Nádasi E, Varga C, Kiss I, Ember I. Gyöngyi Z, et al. Among authors: kiss i. Anticancer Res. 2001 Nov-Dec;21(6A):3937-40. Anticancer Res. 2001. PMID: 11911274

8

In vivo effects of COPP protocol on onco- and suppressor gene expression in a 'follow up study'.

Ember I, Kiss I, Raposa T. Ember I, et al. Among authors: kiss i. In Vivo. 1997 Sep-Oct;11(5):399-402. In Vivo. 1997. PMID: 9427043

9

Effect of 7,12-dimethylbenz(a)anthracene on onco/suppressor gene action in vivo: a short-term experiment.

Ember I, Kiss I, Pusztai Z. Ember I, et al. Among authors: kiss i. Anticancer Res. 1998 Jan-Feb;18(1A):445-7. Anticancer Res. 1998. PMID: 9568117

10

Oncogene and suppressor gene expression as a biomarker for ethylene oxide exposure.

Ember I, Kiss I, Gombköto G, Müller E, Szeremi M. Ember I, et al. Among authors: kiss i. Cancer Detect Prev. 1998;22(3):241-5. doi: 10.1046/j.1525-1500.1998.0oa24.x. Cancer Detect Prev. 1998. PMID: 9618046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

912 results

Search Page

Filters